ūüéČ Health Canada Provides a No Objection Letter for ATMA‚Äôs N500 Phase II Clinical Trial Application

Dear mental healthcare professionals,

A deep heart-felt thank you is warranted to you for bearing the weight of the current mental health crisis, especially during these last tough couple of years. I have heard from many of your peers regarding the increased pressure, overburdening workloads, and feelings of burnout that have become an all too frequent occurrence. Caring for others can be exhausting, and taking care of yourself through these challenging times requires intentional steps of self-care.
 
As the world emerges from a pandemic, the likes of which has not been experienced in many generations, the tsunami of mental health challenges has only increased. The spike in mental healthcare needs has created a shortage of therapy providers, and thus, you are each being asked to do more than ever. Despite these realities, you still show up every day to help where you can.

As an advocate for mental health and wellness for everyone, we care about your well-being. You are the ones that care for other people; as such, it is just as important to address your health and wellness as it is to address those who depend on you for their health and well-being.

ATMA is in the mental wellness business by means of the therapeutic use of psychedelic medicine; sometimes the significance of this work can get lost in the details of running a business. However, last weekend, as we administered psilocybin medicine to fourteen healthcare workers in the first cohort of a clinical trial, it was a reminder of the importance of your mental and spiritual health. A huge measure of our success is related to the improvements we can make in the lives and practices of mental healthcare providers.

Thank you for the work you are doing to help our world make it through these tough times. If you can take a moment, please share with us both your current struggles and successes so that we can better understand how we can serve you in our offerings.
 
Sincerely,

David Harder

Click here to share your story!

 

More News and Media:

ATMA and QI Integrated Health to Become Affiliate Partners

VANCOUVER, BRITISH COLUMBIA, CANADA, December 8, 2022 /EINPresswire.com/ —¬†ATMA Journey Centers Inc. (“ATMA”), a Canadian-based company focused on the providing international psychedelic-assisted therapy training and support for mental healthcare professionals,

Breaking Through the Stigma

By David Harder, ATMA co-founder and co-CEO I met with a gentleman – a pastor of sorts – from my former religious life. We sat down to enjoy a pint